nodes	percent_of_prediction	percent_of_DWPC	metapath
Clemastine—CYP3A4—Cytarabine—lymphatic system cancer	0.139	0.318	CbGbCtD
Clemastine—CYP3A4—Teniposide—lymphatic system cancer	0.137	0.313	CbGbCtD
Clemastine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0958	0.219	CbGbCtD
Clemastine—CYP3A4—Vincristine—lymphatic system cancer	0.0659	0.151	CbGbCtD
Clemastine—Haemolytic anaemia—Mechlorethamine—lymphatic system cancer	0.0162	0.0288	CcSEcCtD
Clemastine—Haemolytic anaemia—Teniposide—lymphatic system cancer	0.012	0.0213	CcSEcCtD
Clemastine—Neuritis—Vincristine—lymphatic system cancer	0.0107	0.019	CcSEcCtD
Clemastine—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.0105	0.0187	CcSEcCtD
Clemastine—Tinnitus—Mechlorethamine—lymphatic system cancer	0.00944	0.0168	CcSEcCtD
Clemastine—Wheezing—Bleomycin—lymphatic system cancer	0.00931	0.0165	CcSEcCtD
Clemastine—Neuropathy peripheral—Teniposide—lymphatic system cancer	0.00815	0.0145	CcSEcCtD
Clemastine—Sweating increased—Fludarabine—lymphatic system cancer	0.00799	0.0142	CcSEcCtD
Clemastine—Vertigo—Mechlorethamine—lymphatic system cancer	0.00792	0.0141	CcSEcCtD
Clemastine—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.0072	0.0128	CcSEcCtD
Clemastine—Neuropathy peripheral—Fludarabine—lymphatic system cancer	0.00717	0.0127	CcSEcCtD
Clemastine—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00705	0.0125	CcSEcCtD
Clemastine—Anorexia—Mechlorethamine—lymphatic system cancer	0.00686	0.0122	CcSEcCtD
Clemastine—Chills—Teniposide—lymphatic system cancer	0.0067	0.0119	CcSEcCtD
Clemastine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00626	0.0111	CcSEcCtD
Clemastine—Diplopia—Carmustine—lymphatic system cancer	0.00607	0.0108	CcSEcCtD
Clemastine—Agitation—Teniposide—lymphatic system cancer	0.00597	0.0106	CcSEcCtD
Clemastine—Chills—Fludarabine—lymphatic system cancer	0.00589	0.0105	CcSEcCtD
Clemastine—Urinary retention—Vincristine—lymphatic system cancer	0.00551	0.0098	CcSEcCtD
Clemastine—Confusional state—Teniposide—lymphatic system cancer	0.00535	0.00951	CcSEcCtD
Clemastine—Agitation—Fludarabine—lymphatic system cancer	0.00525	0.00934	CcSEcCtD
Clemastine—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00519	0.00924	CcSEcCtD
Clemastine—Tachycardia—Teniposide—lymphatic system cancer	0.00518	0.00921	CcSEcCtD
Clemastine—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00513	0.00912	CcSEcCtD
Clemastine—Anorexia—Teniposide—lymphatic system cancer	0.00506	0.00899	CcSEcCtD
Clemastine—Hypotension—Teniposide—lymphatic system cancer	0.00496	0.00882	CcSEcCtD
Clemastine—Convulsion—Fludarabine—lymphatic system cancer	0.00495	0.0088	CcSEcCtD
Clemastine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00492	0.00876	CcSEcCtD
Clemastine—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00475	0.00845	CcSEcCtD
Clemastine—Confusional state—Fludarabine—lymphatic system cancer	0.0047	0.00836	CcSEcCtD
Clemastine—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00466	0.00829	CcSEcCtD
Clemastine—Decreased appetite—Teniposide—lymphatic system cancer	0.00461	0.0082	CcSEcCtD
Clemastine—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.00459	0.00816	CcSEcCtD
Clemastine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00458	0.00814	CcSEcCtD
Clemastine—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00457	0.00813	CcSEcCtD
Clemastine—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00457	0.00812	CcSEcCtD
Clemastine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00451	0.00802	CcSEcCtD
Clemastine—Anorexia—Fludarabine—lymphatic system cancer	0.00444	0.0079	CcSEcCtD
Clemastine—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00438	0.00779	CcSEcCtD
Clemastine—Feeling abnormal—Teniposide—lymphatic system cancer	0.00437	0.00777	CcSEcCtD
Clemastine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00435	0.00774	CcSEcCtD
Clemastine—Chills—Bleomycin—lymphatic system cancer	0.00432	0.00768	CcSEcCtD
Clemastine—Nausea—Mechlorethamine—lymphatic system cancer	0.00427	0.0076	CcSEcCtD
Clemastine—Paraesthesia—Fludarabine—lymphatic system cancer	0.00419	0.00745	CcSEcCtD
Clemastine—Dyspepsia—Fludarabine—lymphatic system cancer	0.0041	0.0073	CcSEcCtD
Clemastine—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00406	0.00722	CcSEcCtD
Clemastine—Decreased appetite—Fludarabine—lymphatic system cancer	0.00405	0.00721	CcSEcCtD
Clemastine—Fatigue—Fludarabine—lymphatic system cancer	0.00402	0.00715	CcSEcCtD
Clemastine—Constipation—Fludarabine—lymphatic system cancer	0.00399	0.00709	CcSEcCtD
Clemastine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00384	0.00683	CcSEcCtD
Clemastine—Asthenia—Teniposide—lymphatic system cancer	0.00381	0.00677	CcSEcCtD
Clemastine—Diarrhoea—Teniposide—lymphatic system cancer	0.00363	0.00645	CcSEcCtD
Clemastine—Chills—Mitoxantrone—lymphatic system cancer	0.0035	0.00623	CcSEcCtD
Clemastine—Confusional state—Bleomycin—lymphatic system cancer	0.00345	0.00613	CcSEcCtD
Clemastine—Vision blurred—Carmustine—lymphatic system cancer	0.00345	0.00613	CcSEcCtD
Clemastine—Tremor—Carmustine—lymphatic system cancer	0.00343	0.00609	CcSEcCtD
Clemastine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00342	0.00608	CcSEcCtD
Clemastine—Vomiting—Teniposide—lymphatic system cancer	0.00337	0.006	CcSEcCtD
Clemastine—Agitation—Carmustine—lymphatic system cancer	0.00336	0.00598	CcSEcCtD
Clemastine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00335	0.00595	CcSEcCtD
Clemastine—Asthenia—Fludarabine—lymphatic system cancer	0.00335	0.00595	CcSEcCtD
Clemastine—Headache—Teniposide—lymphatic system cancer	0.00332	0.00591	CcSEcCtD
Clemastine—Anorexia—Bleomycin—lymphatic system cancer	0.00326	0.00579	CcSEcCtD
Clemastine—Agitation—Vincristine—lymphatic system cancer	0.00321	0.0057	CcSEcCtD
Clemastine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.0032	0.0057	CcSEcCtD
Clemastine—Photosensitivity—Methotrexate—lymphatic system cancer	0.0032	0.0057	CcSEcCtD
Clemastine—Hypotension—Bleomycin—lymphatic system cancer	0.00319	0.00568	CcSEcCtD
Clemastine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00319	0.00567	CcSEcCtD
Clemastine—Convulsion—Carmustine—lymphatic system cancer	0.00317	0.00563	CcSEcCtD
Clemastine—Nausea—Teniposide—lymphatic system cancer	0.00315	0.0056	CcSEcCtD
Clemastine—Vertigo—Vincristine—lymphatic system cancer	0.00314	0.00558	CcSEcCtD
Clemastine—Paraesthesia—Bleomycin—lymphatic system cancer	0.00307	0.00546	CcSEcCtD
Clemastine—Convulsion—Vincristine—lymphatic system cancer	0.00302	0.00538	CcSEcCtD
Clemastine—Confusional state—Carmustine—lymphatic system cancer	0.00301	0.00535	CcSEcCtD
Clemastine—Decreased appetite—Bleomycin—lymphatic system cancer	0.00297	0.00528	CcSEcCtD
Clemastine—Vomiting—Fludarabine—lymphatic system cancer	0.00296	0.00527	CcSEcCtD
Clemastine—Convulsion—Mitoxantrone—lymphatic system cancer	0.00295	0.00524	CcSEcCtD
Clemastine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00292	0.0052	CcSEcCtD
Clemastine—Headache—Fludarabine—lymphatic system cancer	0.00292	0.00519	CcSEcCtD
Clemastine—Tachycardia—Carmustine—lymphatic system cancer	0.00291	0.00518	CcSEcCtD
Clemastine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00285	0.00507	CcSEcCtD
Clemastine—Anorexia—Carmustine—lymphatic system cancer	0.00284	0.00506	CcSEcCtD
Clemastine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00282	0.00501	CcSEcCtD
Clemastine—Confusional state—Mitoxantrone—lymphatic system cancer	0.0028	0.00497	CcSEcCtD
Clemastine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00279	0.00496	CcSEcCtD
Clemastine—Hypotension—Carmustine—lymphatic system cancer	0.00279	0.00496	CcSEcCtD
Clemastine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00277	0.00493	CcSEcCtD
Clemastine—Nausea—Fludarabine—lymphatic system cancer	0.00277	0.00492	CcSEcCtD
Clemastine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00275	0.0049	CcSEcCtD
Clemastine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00272	0.00483	CcSEcCtD
Clemastine—Anorexia—Vincristine—lymphatic system cancer	0.00272	0.00483	CcSEcCtD
Clemastine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00271	0.00481	CcSEcCtD
Clemastine—Insomnia—Carmustine—lymphatic system cancer	0.0027	0.0048	CcSEcCtD
Clemastine—Irritability—Methotrexate—lymphatic system cancer	0.00268	0.00477	CcSEcCtD
Clemastine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00268	0.00477	CcSEcCtD
Clemastine—Paraesthesia—Carmustine—lymphatic system cancer	0.00268	0.00476	CcSEcCtD
Clemastine—Hypotension—Vincristine—lymphatic system cancer	0.00266	0.00473	CcSEcCtD
Clemastine—Somnolence—Carmustine—lymphatic system cancer	0.00265	0.00472	CcSEcCtD
Clemastine—Anorexia—Mitoxantrone—lymphatic system cancer	0.00264	0.0047	CcSEcCtD
Clemastine—Decreased appetite—Carmustine—lymphatic system cancer	0.00259	0.00461	CcSEcCtD
Clemastine—Hypotension—Mitoxantrone—lymphatic system cancer	0.00259	0.00461	CcSEcCtD
Clemastine—Insomnia—Vincristine—lymphatic system cancer	0.00258	0.00458	CcSEcCtD
Clemastine—Paraesthesia—Vincristine—lymphatic system cancer	0.00256	0.00455	CcSEcCtD
Clemastine—Constipation—Carmustine—lymphatic system cancer	0.00255	0.00454	CcSEcCtD
Clemastine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00249	0.00443	CcSEcCtD
Clemastine—Decreased appetite—Vincristine—lymphatic system cancer	0.00248	0.0044	CcSEcCtD
Clemastine—Somnolence—Mitoxantrone—lymphatic system cancer	0.00247	0.00439	CcSEcCtD
Clemastine—Feeling abnormal—Carmustine—lymphatic system cancer	0.00246	0.00437	CcSEcCtD
Clemastine—Fatigue—Vincristine—lymphatic system cancer	0.00246	0.00437	CcSEcCtD
Clemastine—Asthenia—Bleomycin—lymphatic system cancer	0.00245	0.00436	CcSEcCtD
Clemastine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00244	0.00434	CcSEcCtD
Clemastine—Constipation—Vincristine—lymphatic system cancer	0.00244	0.00433	CcSEcCtD
Clemastine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00241	0.00429	CcSEcCtD
Clemastine—Fatigue—Mitoxantrone—lymphatic system cancer	0.00239	0.00425	CcSEcCtD
Clemastine—Constipation—Mitoxantrone—lymphatic system cancer	0.00237	0.00422	CcSEcCtD
Clemastine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00229	0.00407	CcSEcCtD
Clemastine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00222	0.00395	CcSEcCtD
Clemastine—Vomiting—Bleomycin—lymphatic system cancer	0.00217	0.00387	CcSEcCtD
Clemastine—Drowsiness—Methotrexate—lymphatic system cancer	0.00217	0.00385	CcSEcCtD
Clemastine—Asthenia—Carmustine—lymphatic system cancer	0.00214	0.00381	CcSEcCtD
Clemastine—Asthenia—Vincristine—lymphatic system cancer	0.00204	0.00363	CcSEcCtD
Clemastine—Diarrhoea—Carmustine—lymphatic system cancer	0.00204	0.00363	CcSEcCtD
Clemastine—Nausea—Bleomycin—lymphatic system cancer	0.00203	0.00361	CcSEcCtD
Clemastine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00202	0.0036	CcSEcCtD
Clemastine—Asthenia—Mitoxantrone—lymphatic system cancer	0.00199	0.00354	CcSEcCtD
Clemastine—Dizziness—Carmustine—lymphatic system cancer	0.00197	0.00351	CcSEcCtD
Clemastine—Diarrhoea—Vincristine—lymphatic system cancer	0.00195	0.00347	CcSEcCtD
Clemastine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.0019	0.00338	CcSEcCtD
Clemastine—Vomiting—Carmustine—lymphatic system cancer	0.0019	0.00337	CcSEcCtD
Clemastine—Dizziness—Vincristine—lymphatic system cancer	0.00188	0.00335	CcSEcCtD
Clemastine—Headache—Carmustine—lymphatic system cancer	0.00187	0.00332	CcSEcCtD
Clemastine—Tinnitus—Methotrexate—lymphatic system cancer	0.00181	0.00323	CcSEcCtD
Clemastine—Vomiting—Vincristine—lymphatic system cancer	0.00181	0.00322	CcSEcCtD
Clemastine—Headache—Vincristine—lymphatic system cancer	0.00178	0.00317	CcSEcCtD
Clemastine—Nausea—Carmustine—lymphatic system cancer	0.00177	0.00315	CcSEcCtD
Clemastine—Vomiting—Mitoxantrone—lymphatic system cancer	0.00176	0.00314	CcSEcCtD
Clemastine—Chills—Methotrexate—lymphatic system cancer	0.00175	0.0031	CcSEcCtD
Clemastine—Headache—Mitoxantrone—lymphatic system cancer	0.00174	0.00309	CcSEcCtD
Clemastine—Nausea—Vincristine—lymphatic system cancer	0.00169	0.00301	CcSEcCtD
Clemastine—Nausea—Mitoxantrone—lymphatic system cancer	0.00165	0.00293	CcSEcCtD
Clemastine—Vision blurred—Methotrexate—lymphatic system cancer	0.0016	0.00284	CcSEcCtD
Clemastine—Vertigo—Methotrexate—lymphatic system cancer	0.00152	0.00271	CcSEcCtD
Clemastine—Convulsion—Methotrexate—lymphatic system cancer	0.00147	0.00261	CcSEcCtD
Clemastine—Confusional state—Methotrexate—lymphatic system cancer	0.00139	0.00248	CcSEcCtD
Clemastine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00138	0.00246	CcSEcCtD
Clemastine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00135	0.00241	CcSEcCtD
Clemastine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00134	0.00238	CcSEcCtD
Clemastine—Anorexia—Methotrexate—lymphatic system cancer	0.00132	0.00234	CcSEcCtD
Clemastine—Hypotension—Methotrexate—lymphatic system cancer	0.00129	0.0023	CcSEcCtD
Clemastine—Insomnia—Methotrexate—lymphatic system cancer	0.00125	0.00222	CcSEcCtD
Clemastine—Paraesthesia—Methotrexate—lymphatic system cancer	0.00124	0.00221	CcSEcCtD
Clemastine—Somnolence—Methotrexate—lymphatic system cancer	0.00123	0.00219	CcSEcCtD
Clemastine—Dyspepsia—Methotrexate—lymphatic system cancer	0.00122	0.00216	CcSEcCtD
Clemastine—Decreased appetite—Methotrexate—lymphatic system cancer	0.0012	0.00214	CcSEcCtD
Clemastine—Fatigue—Methotrexate—lymphatic system cancer	0.00119	0.00212	CcSEcCtD
Clemastine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00114	0.00203	CcSEcCtD
Clemastine—Asthenia—Methotrexate—lymphatic system cancer	0.000992	0.00176	CcSEcCtD
Clemastine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000946	0.00168	CcSEcCtD
Clemastine—Dizziness—Methotrexate—lymphatic system cancer	0.000914	0.00163	CcSEcCtD
Clemastine—Vomiting—Methotrexate—lymphatic system cancer	0.000879	0.00156	CcSEcCtD
Clemastine—Headache—Methotrexate—lymphatic system cancer	0.000866	0.00154	CcSEcCtD
Clemastine—Nausea—Methotrexate—lymphatic system cancer	0.000821	0.00146	CcSEcCtD
